Farther Finance Advisors LLC lowered its position in Chemed Co. (NYSE:CHE – Free Report) by 63.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 122 shares of the company’s stock after selling 216 shares during the period. Farther Finance Advisors LLC’s holdings in Chemed were worth $65,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. UMB Bank n.a. boosted its stake in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after purchasing an additional 39 shares during the period. Trust Co. of Vermont purchased a new position in shares of Chemed in the 4th quarter valued at approximately $34,000. Tortoise Investment Management LLC boosted its holdings in shares of Chemed by 77.3% during the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after buying an additional 34 shares in the last quarter. SRS Capital Advisors Inc. boosted its stake in Chemed by 39.2% during the fourth quarter. SRS Capital Advisors Inc. now owns 135 shares of the company’s stock worth $72,000 after acquiring an additional 38 shares in the last quarter. Finally, Allworth Financial LP grew its stake in shares of Chemed by 2,057.1% in the 4th quarter. Allworth Financial LP now owns 151 shares of the company’s stock worth $83,000 after buying an additional 144 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.
Chemed Price Performance
Shares of NYSE:CHE opened at $594.41 on Friday. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $648.29. The firm’s 50 day simple moving average is $567.72 and its two-hundred day simple moving average is $565.52. The company has a market capitalization of $8.70 billion, a P/E ratio of 30.04, a P/E/G ratio of 2.15 and a beta of 0.43.
Chemed Dividend Announcement
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada raised their price target on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.
Check Out Our Latest Analysis on Chemed
Insiders Place Their Bets
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Brian C. Judkins bought 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company’s stock.
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- What is a support level?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- How to start investing in penny stocks
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- What is MarketRank� How to Use it
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.